日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biosensor and machine learning-aided engineering of an amaryllidaceae enzyme

石蒜科酶的生物传感器和机器学习辅助工程

Simon d'Oelsnitz, Daniel J Diaz, Wantae Kim, Daniel J Acosta, Tyler L Dangerfield, Mason W Schechter, Matthew B Minus, James R Howard, Hannah Do, James M Loy, Hal S Alper, Y Jessie Zhang, Andrew D Ellington

Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma

Elotuzumab增强SLAMF7同型相互作用,从而改善NK细胞对多发性骨髓瘤的杀伤作用

Tatiana Pazina ,Ashley M James ,Kimberly B Colby ,Yibin Yang ,Andrew Gale ,Amy Jhatakia ,Alper Y Kearney ,Robert F Graziano ,Natalie A Bezman ,Michael D Robbins ,Adam D Cohen ,Kerry S Campbell

PD-1 blockade enhances elotuzumab efficacy in mouse tumor models

PD-1 阻断可增强小鼠肿瘤模型中的埃罗妥珠单抗疗效

Natalie A Bezman, Amy Jhatakia, Alper Y Kearney, Ty Brender, Mark Maurer, Karla Henning, Misty R Jenkins, Amy J Rogers, Paul J Neeson, Alan J Korman, Michael D Robbins, Robert F Graziano

Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial

接受舒尼替尼治疗的晚期非透明细胞肾细胞癌患者的高血压和循环细胞因子及血管生成因子:II 期试验结果

Mehmet Asim Bilen, Amado J Zurita, Nasreen A Ilias-Khan, Hsiang-Chun Chen, Xuemei Wang, Alper Y Kearney, Sherie Hodges, Eric Jonasch, Shixia Huang, Aarif Yusuf Khakoo, Nizar M Tannir

ARF: connecting senescence and innate immunity for clearance

ARF:连接衰老和先天免疫以清除

Kearney, Alper Y; Anchang, Benedict; Plevritis, Sylvia; Felsher, Dean W

8-Chloroadenosine Sensitivity in Renal Cell Carcinoma Is Associated with AMPK Activation and mTOR Pathway Inhibition

肾细胞癌中的 8-氯腺苷敏感性与 AMPK 激活和 mTOR 通路抑制有关

Alper Y Kearney, You-Hong Fan, Uma Giri, Babita Saigal, Varsha Gandhi, John V Heymach, Amado J Zurita